Traws Pharma

(NASDAQ) ONTX

Current PriceN/A

Market CapN/A

Since IPO (2013)-100%

5 Year-99%

1 Year+5%

1 Month+12%

Traws Pharma Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$2.79B

Net Income (TTM)

-$19.43M

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

ONTX News

Why Jabil Circuit, Inc., Onconova Therapeutics Inc., and Gogo Inc. Plunged Today

Dan CaplingerDec 18, 2013

Why Onconova Therapeutics Inc. Shares Crashed

Sean WilliamsDec 18, 2013

Keep an Eye on Onconova, Enzymotec, DepoMed, and Omeros Today

Leo SunDec 18, 2013

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Traws Pharma

Industry

Pharmaceuticals

Sector

Health Care

Employees

CEO

Iain David Dukes, PhD

Website

www.trawspharma.com

Headquarters

Newtown, PA 18940, US

ONTX Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

Return on Capital

1376%

Return on Assets

-2%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/A

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

$0.00

Operating Income

-$17.88B

EBITDA

-$17.88M

Operating Cash Flow

-$18.19B

Capital Expenditure

$0.00

Free Cash Flow

-$18.19B

Cash & ST Invst.

$3.82B

Total Debt

$0.00

Traws Pharma Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

-100.0%

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

N/A

Market Cap/Employee

N/A

Employees

N/A

Net Income

-$7.11M

-133.1%

EBITDA

-$6.95M

-33.5%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$3.13M

-80.3%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-1.78%

N/A

Return on Invested Capital

1376.36%

N/A

Free Cash Flow

-$2.58B

-47279.1%

Operating Cash Flow

-$2.58B

-47279.1%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

MEIPMEI Pharma, Inc.

MEIPMEI Pharma, Inc.$3.07+10.43%

MTVAMetaVia Inc.

MTVAMetaVia Inc.$2.84-8.39%

ELEVElevation Oncology, Inc.

ELEVElevation Oncology, Inc.$0.37-2.12%

PIRSPieris Pharmaceuticals, Inc.

PIRSPieris Pharmaceuticals, Inc.$13.60-15.58%

NYMXFNymox Pharmaceutical Corporation

NYMXFNymox Pharmaceutical Corporation$0.15-3.00%

DOMHDominari Holdings Inc.

DOMHDominari Holdings Inc.$3.70+7.25%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

SPCEVirgin Galactic

SPCEVirgin Galactic$6.18+0.36%

FFord Motor Company

FFord Motor Company$17.44+0.05%

ONDSOndas

ONDSOndas$13.22-0.00%

NOKNokia

NOKNokia$14.84-0.03%

BBAIBigBear.ai

BBAIBigBear.ai$5.04+0.02%

TAT&T

TAT&T$24.80-0.00%

HPEHewlett Packard Enterprise

HPEHewlett Packard Enterprise$43.04+0.13%

Questions About ONTX

What is the current price of Traws Pharma?

Traws Pharma is trading at N/A per share.

What is the 52-week range for Traws Pharma?

Over the past 52 weeks, Traws Pharma has traded between N/A and N/A.

How much debt does Traws Pharma have?

As of the most recent reporting period, Traws Pharma reported total debt of $0.00.

How much cash does Traws Pharma have on hand?

Traws Pharma reported $3.13M in cash and cash equivalents in its most recent financial results.

What is Traws Pharma’s dividend yield?

Traws Pharma does not currently have a dividend yield.

Traws Pharma

Traws Pharma Financials at a Glance

ONTX News

Traws Pharma Posts Q2 Revenue Jump

Why Onconova Therapeutics Stock Soared Today

This Week in Biotech: Buyouts, an FDA Approval, and Clinical Data. Oh, My!

3 Horrendous Health-Care Stocks This Week

Why Onconova Therapeutics Inc. Shares Imploded

Why Jabil Circuit, Inc., Onconova Therapeutics Inc., and Gogo Inc. Plunged Today

Why Onconova Therapeutics Inc. Shares Crashed

Keep an Eye on Onconova, Enzymotec, DepoMed, and Omeros Today

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Traws Pharma

ONTX Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Traws Pharma Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About ONTX

What is the current price of Traws Pharma?

What is the 52-week range for Traws Pharma?

How much debt does Traws Pharma have?

How much cash does Traws Pharma have on hand?

What is Traws Pharma’s dividend yield?

Premium Investing Services